ABSTRACT
The consensus of evidence over the last two decades is that increasing the dietary intake of longer-chain ω-3 (n-3) polyunsaturated fatty acids (PUFA), especially eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3), is beneficial in various human disorders including cardiovascular and inflammatory conditions. A related issue is the requirement of DHA for normal neural development in the human fetus and premature infants. Fatty fish and fish oils are rich sources of EPA and DHA.
